Improving surgical access for patients with primary hyperparathyroidism
Official title: Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism
Run by University of Pennsylvania · NCT06562881 · Data updated 2026-11-12
This study is testing if helping patients with primary hyperparathyroidism get better support and guidance can improve their chances of getting timely surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 76 (estimated) |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | October 1, 2026 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | August 27, 2026 |
| Trial ID | NCT06562881 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with primary hyperparathyroidism who belong to racial or ethnic minority groups and meet specific clinical criteria for surgical treatment.
✕Probably not a fit
Patients who have previously undergone parathyroidectomy or have end-stage renal disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance surgical health equity for historically marginalized patients diagnosed with primary hyperparathyroidism (PHPT) by implementing patient navigation strategies. It investigates how these navigation efforts, including direct outreach and appointment scheduling, affect the rates of surgical consultations and surgeries among participants. The study will randomize participants to receive or not receive navigation support, with a crossover design allowing those initially not receiving navigation to access it after three months. The focus is on improving timely access to parathyroidectomy, a curative and low-risk surgery for PHPT.
Why it matters
Potential benefit: If successful, this study could significantly increase the rates of surgical treatment for marginalized patients with primary hyperparathyroidism, improving their quality of life.
How similar studies have gone: Other studies have shown success in using patient navigation to improve access to surgical care, indicating that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with PHPT and not yet had parathyroidectomy who meet criteria for surgical treatment of PHPT (osteoporosis, fragility fracture, or evidence of vertebral compression fracture on spine imaging, renal involvement \[renal stone, silent nephrolithiasis on renal imaging, nephrocalcinosis, hypercalciuria (24-hour urine calcium level 400 mg/dL) with increased stone risk, or impaired renal function (glomerular filtration rate 60 mL/min)\], calcium 1 mg/dL above upper limit of normal, age less than 50) * Qualify as a member of a racial or ethnic minority group (Black, Hispanic, Asian and Pacific Islander, Native American), lower socioeconomic neighborhoods (by zipcode), socially vulnerable (social determinants of health indicating financial strain, social vulnerability index in the top quartile 75%+ by zip code), or with underinsurance (Medicaid, Medicare, dual eligible, uninsured) Exclusion Criteria: * Prior Parathyroidectomy * End-stage Renal Disease * Renal Transplant * Vitamin D Deficiency * Metastatic Disease * Familial Hypocalciuric Hypercalcemia * No Indication for Surgery * Unable/Unwilling to provide consent
Where it's running
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Rachel Kelz, MD — University of Pennsylvania
- Study coordinator: Jasmine Hwang, MD
- Email: Jasmine.Hwang@pennmedicine.upenn.edu
- Phone: (267) 251-2835
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using autofluorescence imaging during surgery for primary hyperparathyroidism
This study tests if using special imaging during surgery can help doctors find and remove the right parathyroid glands in patients with primary hyperparathyroidism.
-
Flurpiridaz F-18 PET/CT to Find Parathyroid Adenomas
This study tests whether Flurpiridaz F-18 PET/CT can better detect abnormal parathyroid glands in adults with primary hyperparathyroidism before surgery.
-
Low-intensity focused ultrasound targeting the subthalamic nucleus for OCD
A short test is being done to see if a wearable, non-invasive ultrasound device can safely and tolerably help adults with OCD by targeting a brain region called the subthalamic nucleus.
-
Safe firearm storage: preferred device choice vs. standard cable locks
This study tests whether giving people a choice of storage devices for firearms leads to safer storage at home compared with just sending cable locks.
-
Add-on anti-inflammatory therapy for adults with depression and high inflammation
This study tests whether adalimumab, given with your regular antidepressant Lexapro, can improve depressive symptoms in adults with major depressive disorder and high inflammation.
-
FAP PET/CT in adults with pulmonary TB
This early-phase study tests whether a FAP PET/CT scan can map lung fibrosis in adults with pulmonary TB before starting treatment and after cure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.